期刊文献+

小檗碱对动脉粥样硬化性损伤的保护作用 被引量:2

Protective Effect of Berberine on Atherosclerotic Injury
原文传递
导出
摘要 目的:探讨小檗碱对动脉粥样硬化损伤的保护作用。方法:将56只大鼠,随机分为对照组(C),高脂饮食假手术组(HD),肾动脉狭窄组(RAS),肾动脉狭窄高脂饮食组(HD+RAS)。C及RAS组给予正常饮食,HD及HD+RAS组给予高脂饮食,RAS及HD+RAS组采用固定内径银夹夹左肾动脉。饲养12周,每组处死6只进行检测,剩余除C外每日灌胃小檗碱(150mg/kg),C予以等量生理盐水灌服,持续4周,四周后处死进行相同检测,用药前后结果进行对比评价小檗碱功能。结果:与C相比,HD,RAS,HD+RAS组肌酐显著升高(P<0.05),HD及HD+RAS组胆固醇明显升高(P<0.05),超氧化物歧化酶(SOD)在HD,RAS及HD+RAS组显著降低(P<0.05),丙二醛(MDA)在HD,RAS及HD+RAS组显著增高(P<0.05),血管内皮生长因子VEGF在HC,RAS及HD+RAS组表达量升高。给予小檗碱灌胃处理后,检测指标各组间无统计学差异(P>0.05)。结论:小檗碱对动脉粥样硬化性损伤具有良好的保护作用。 Objective:To investigate the protect effect of Berberine on atherosclerotic injury.Methods:Fifty-six rats were randomly divided into control group(C),high-fat diet group(HD),renal artery stenosis group(RAS),high-fat diet with renal artery stenosis group(HD+RAS),fourteen in each group.C and RAS were given proper diet,HD and HD+RAS were given high fat diet.RAS and HD+RAS were clamped by sliver clip with a fixed diameter on left renal artery.12 weeks later,executed six of every group for testing,the left were given Berberine(150mg/kg) every day except C,C were given saline.4 weeks later,the left rats were executed for the same testing.Results:Compared with C,Creatinine was significantly higher in other three groups(p〈0.05).Cholesterol was significantly higher in HD and HD+RAS groups(p0.05).SOD was Significantly higher while MDA was Significantly lower in HD,RAS and HD+RAS group.The ex-pression of VEGF was significantly higher in HD,RAS and HD+RAS group.After given berberine,the testing results had no significant difference in different groups.Conclusions:Berberine has good protection effect on atherosclerotic injury.
出处 《现代生物医学进展》 CAS 2011年第2期223-226,共4页 Progress in Modern Biomedicine
基金 中华医学会临床医学科研专项资金项目(09010290184)
关键词 小檗碱 动脉粥样硬化性损伤 SOD MDA VEGF Berberine Atherosclerotic injury SOD MDA VEGF
  • 相关文献

参考文献1

二级参考文献24

  • 1[1]Vasquez - Vivar J, Kalyanaraman B, Martasek P,et al . Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors[ J]. Proc Natl Acad Sci USA, 1998,95(16) :9 220 ~ 9 225.
  • 2[2]Brennan M L, Wu W, Fu X, et al . A tale of two controversies: defining both the role of peroxidases in nitotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase - deficient mice, and the nature of peroxidase- generated reactive nitrogen species [ J]. J Biol Chem,2002,277(20): 17 415 ~ 17 427.
  • 3[3]Roberts L J, Morrow J D. Products of the isoprostane pathway:unique bioactive compounds and markers of lipid peroxidation [ J ]. Cell Mol Life Sci, 2002, 59(5) :808 ~ 820.
  • 4[4]Lawson J A, Li H, Rokkach J, et al . Identification of two major F2 isoprostanes, 8,12 - iso - and 5 - cpi -8,12- iso- isoprostane F2alpha- Ⅵ in human urine[J].J Biol Chem, 1998,273(45) :29 295 ~ 29 301.
  • 5[5]Cyrus T, Pratico D,Zhao L, et al .Absence of 12/15- lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E - deficient mice[J]. Circulation,2001,103(18) :2 277 ~ 2 282.
  • 6[6]Heinecke J W. Oxidized amino acids: culprits in human arteriosclerosis and indicators of oxidative stress[J].Free Radic Biol Med,2002,32(11):1 090~ 1 101.
  • 7[7]Helbock H J,Beckman K B,Shigenage M K, et al . DNA oxidation matter the HPLC - electrochemical detection assay of 8 - oxo - deoxyguanosine and 8 - oxo -guanine[J]. Proc Natl Acad Sci USA, 1998,95 ( 1 ): 288~ 293.
  • 8[8]Wu L L, Chiou C C, Chang P Y, et al . Urinary 8- OHdG: a marker of oxidative- stress to DNA and a risk factor for cancer, atherosclerosis and diabetics[J].Clin Chim Acta,2004,339(1 - 2): 1 ~ 9.
  • 9[9]Liao F, Andalibi A, Qiao J H, et al . Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice[J]. J Clin Invest, 1994,94(2): 877 ~884.
  • 10[10]Pratico D, Tangirala R K, Rader D J, et al .Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in APOE deficient mice [J]. Nat Med, 1998,4(10): 1 189 ~ 1 192.

共引文献16

同被引文献39

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部